A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Withdrawn before enrolling · Phase 3

Conditions studied: Advanced Biliary Tract Cancer

In brief

An open label study to determine the efficacy and safety of SPARC1507

Key facts

Study ID

NCT02597465

Run by

Sun Pharma Advanced Research Company Limited

People needed

0

Starts

2018-12-01

Expected to finish

2019-12-01

Last updated by the study team

2020-12-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Evidence of advanced/metastatic biliary tract cancer
• Male or female ≥ 18 years old
• Participants must have measurable disease according to RECIST
• ECOG performance status ≤ 1

You may not qualify if…

• Known hypersensitivity to trial treatments, or their excipients
• Prior history of treatment with any taxane therapy
• Cardiovascular disorders as per Investigator's discretion
• The subject has received radiation therapy

Where it is running

• SPARC study site — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.